Bayer Archives - DelveInsight

Bayer

pharma-happenings-for-jnj-bayer-novo-prothena
Bayer’s CKD Drug; Enochian’s RNA Hijack for HBV; Novo Nordisk’s to get Prothena̵...

Bayer Scores FDA-Approval for its CKD Drug FinerenoneFollowing a priority review, the USFDA finally gave its thumbs-up to Bayer AG’s Kerendia (finerenone) for chronic kidney disease (CKD) asso...


KaliVir, Astellas deal; AbCellera IPO; Bayer's CAR-T collabs; NASH therapy
KaliVir, Astellas licensing deal; AbCellera’s IPO; Bayer CAR-T Cell therapy collab with Ata...

KaliVir, Astellas Pharma forms a licensing deal for VET2-L2 oncolytic virusKaliVir Immunotherapeutics and Astellas Pharma entered into a worldwide exclusive licensing agreement for the develop...


Pharma news for Bayer, Novartis, Forma, AskBio
Bayer eyes AskBio’s Gene Therapies; Novartis’ Iptacopan; Forma’s IDH1-Mutated AML The...

Bayer Set to Fork Over USD 4 Billion for AskBio’s Gene TherapiesGermany-based Bayer is set to acquire North Carolina-based Asklepios BioPharmaceutical (AskBio) with motives to get its hands on...


Pharma news for Bayer Verona Cycle Pharma
Cycle Pharmaceuticals’ USD 25M Debt Financing; Bayer’s Phase IV REPLACE Trial; Verona’...

Cycle Pharmaceuticals Hauls In USD 25 Million In A Debt Financing Agreement Cycle Pharmaceuticals, a biotech company focusing exclusively on rare diseases, announced a strategic financing...


Default Blog Image
Merck; Bayer; Shionogi set to showcase their candidates indicated for Chronic RefractoryCough in ...

Merck’s Gefapixant could become the first drug approved for Chronic CoughATS 2020 Virtual is happening from August 5 to August 10, and it is exciting to watch major Respiratory /Pulmonary Phar...


Soft Tissue Sarcoma
Soft Tissue Sarcoma: A rare malignancy

What does a yellow ribbon signify? It symbolizes support for Sarcoma patients. Sarcoma – an umbrella term for several forms of cancer that occur in muscles or bones – is a rare form of cancer. The...


Pharma News
Fujifilm acquires global rights to Cynata’s novel therapy for GvHD; Themis raises EURO 40 m...

FUJIFILM Corporation has signed an exclusive licensing agreement with an Australian bio-venture Cynata Therapeutics Limited for CYP-001.Under the agreement, FUJIFILM will gain rights to devel...


Pharma News
GNA Biosolutions raises USD 13.5M; AC Immune collaborates with Penn; Jazz Pharmaceuticals acquire...

GNA Biosolutions nets USD 13.5 Million in a Series C FundingGNA Biosolutions has secured USD 13.5 Million completing its all the rounds of financing. GNA Biosolutions GmbH, a Germany-based mo...


Recent Pharma News
Recursion Pharmaceuticals nets USD 121M; Bayer’s MRI agent gets a nod

AI-powered drug-maker Recursion Pharmaceuticals secures USD 121 M to accelerate its clinical programsRecursion Pharmaceuticals, a next-gen biopharma company, has raised USD 121 Million in Ser...


Neurogene
Apollomics raises; Pear Therapeutics raises $64M; Lilly to acquire Loxo

Apollomics raises USD 100 Million for funding of transpacific cancer R&D planApollomics has raised USD 100 million for funding an oncology clinical trial program. The series B ro...


Editor's Pick
Bone Metastasis Market: A Debilitating Consequence for Many Tumors

In advanced cancer patients, the most common site for the occurrence of metastasis is c...

Evaluating the Role of Digital Therapeutics as an Alternative to Conventional...

Depression is a mental condition characterized by prolonged series of poor moods, loss ...

Exploring the Market Potential of the Upcoming Therapies for the Myasthenia G...

Myasthenia Gravis is an autoimmune disease that causes muscle weakness and fatigue. It ...

Scrutinizing the West Syndrome Market Space from Growth Perspectives

West syndrome is a rare form of neurological disorder, an age-related specific Epilepti...

Recent Inclination of Pharma Companies, Emerging Pipeline Therapies Drive the...

Chronic diseases (CDs) pose a significant challenge to healthcare in the 21st century. ...

ASCO Conference 2021
ASCO Conference 2021

The American Society of Clinical Oncology is a platform that provides a global connection to researchers, pharma companies, and healthcare professions standing against cancer, finding a cure for it.